also allowing it to offer its manufacturing services to other pharmaceutical companies. Grifols has plans to release its 2023 annual financial report on 29 February. "Grifols prepares for late ...

Grifols said it plans to outline its strategy ... takeover bid. The Spanish pharmaceutical company said late Wednesday that it would soon schedule an investor update at which it would present ...

The family that owns Spanish drugmaker Grifols ... The company, first formed in 1909 and headquartered in Barcelona, is a manufacturer of plasma-based pharmaceuticals and other products like ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator ...

MADRID (Reuters) - U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical ...

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in court.

Canadian fund Brookfield said it had dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value, while Grifols said it ...

Spanish pharma Grifols is leveraging its massive collection ... will be spearheaded by Grifols’ subsidiary Alkahest, the company said in a Jan. 14 release. The MJFF’s funds will power a ...

The American investment company Brandes Investment Partners LP has acquired a stake in the Spanish pharmaceutical company Grifols SA amid plans by Canadian Brookfield Asset Management to acquire ...

Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission ...

U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols ...